Business Context and Reporting Period
This Form 8-K is a current report filed by Aikido Pharma Inc. (not Dominari Holdings Inc.) on July 19, 2021. The filing addresses Item 8.01 (Other Events) regarding the scheduling of the company's 2021 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is the rescheduling of the 2021 Annual Meeting of Shareholders. The meeting date has been changed by more than 30 days from the anniversary of the last annual meeting. Consequently, the deadline for shareholders to submit director nominations or proposals has been updated.
Guidance, Outlook, and Management Commentary
- Meeting Date: The Board of Directors confirmed the 2021 Annual Meeting will be held on Tuesday, October 5, 2021.
- Submission Deadline: Shareholders wishing to nominate a director or propose business must submit notice by August 2, 2021.
- Future Filings: Specific details regarding the time, location, and matters to be considered will be included in the definitive proxy statement to be filed with the SEC in due course.
Key Facts for Investor Verification
- Verify the correct registrant name is Aikido Pharma Inc. (Ticker: AIKI), as the input metadata referenced "Dominari Holdings Inc."
- Confirm the new Annual Meeting date of October 5, 2021.
- Note the strict deadline of August 2, 2021 for submitting shareholder proposals or director nominations.
- Monitor for the upcoming definitive proxy statement for full meeting details.